DE ROSA, VERONICA
 Distribuzione geografica
Continente #
AS - Asia 1.680
NA - Nord America 1.032
EU - Europa 576
SA - Sud America 323
Continente sconosciuto - Info sul continente non disponibili 229
AF - Africa 23
OC - Oceania 3
Totale 3.866
Nazione #
US - Stati Uniti d'America 983
SG - Singapore 588
CN - Cina 423
BR - Brasile 262
IT - Italia 231
VN - Vietnam 157
HK - Hong Kong 149
JP - Giappone 99
KR - Corea 89
FR - Francia 86
NL - Olanda 61
BD - Bangladesh 56
FI - Finlandia 53
DE - Germania 34
GB - Regno Unito 32
IN - India 32
CA - Canada 22
AR - Argentina 20
EC - Ecuador 16
IL - Israele 15
ID - Indonesia 14
IQ - Iraq 13
MX - Messico 12
IE - Irlanda 10
ES - Italia 9
PL - Polonia 9
CO - Colombia 8
RU - Federazione Russa 8
VE - Venezuela 7
AT - Austria 6
JM - Giamaica 6
SE - Svezia 6
TR - Turchia 6
UZ - Uzbekistan 6
PK - Pakistan 5
PT - Portogallo 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
KZ - Kazakistan 4
TN - Tunisia 4
UA - Ucraina 4
AZ - Azerbaigian 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
MA - Marocco 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
LB - Libano 2
LT - Lituania 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
NE - Niger 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.638
Città #
Singapore 336
Hefei 203
Santa Clara 175
Hong Kong 144
San Jose 103
Ashburn 98
Seoul 87
Tokyo 84
Los Angeles 80
Marigliano 80
Beijing 70
Lauterbourg 69
Ho Chi Minh City 62
Dallas 41
Hanoi 36
Helsinki 29
New York 24
São Paulo 23
Orem 20
Turku 20
Naples 18
Ercolano 17
Seattle 17
Minamishinagawa 13
Frankfurt am Main 12
Atlanta 11
Buffalo 11
Da Nang 11
Bengaluru 10
Chicago 10
Milan 10
Rome 10
Amsterdam 9
Dublin 9
Guayaquil 9
Haiphong 9
Brasília 8
Curitiba 7
Florence 7
Manchester 7
Munich 7
Vienna 7
Caxias do Sul 6
Chennai 6
Montreal 6
Portsmouth 6
Tashkent 6
Warsaw 6
Belo Horizonte 5
Denver 5
Formia 5
Fort Worth 5
Houston 5
London 5
Mexico City 5
Paris 5
Porto Alegre 5
Stockholm 5
Boardman 4
Dhaka 4
Düsseldorf 4
Goiânia 4
Mumbai 4
Nuremberg 4
Teggiano 4
Thái Bình 4
Zurich 4
Amman 3
Aparecida de Goiânia 3
Baghdad 3
Baku 3
Bauru 3
Bogotá 3
Boston 3
Charlotte 3
City of London 3
Helena 3
Hải Dương 3
Jacksonville 3
Johannesburg 3
Kingston 3
Miami 3
Nairobi 3
Ninh Bình 3
Palermo 3
Philadelphia 3
Plainfield 3
Quito 3
Recife 3
Salto 3
Salvador 3
San Francisco 3
Turin 3
Valenza 3
Wuhan 3
Anita Garibaldi 2
Antioch 2
Arcadia 2
Barretos 2
Belém 2
Totale 2.229
Nome #
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival 105
Metabolic control of immune tolerance in health and autoimmunity 96
Epigenetics: An opportunity to shape innate and adaptive immune responses 92
Caloric Restriction Promotes Immunometabolic Reprogramming Leading to Protection from Tuberculosis 92
T cell metabolism and susceptibility to autoimmune diseases 92
Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions 81
Editorial: Inborn Errors of Immunity (IEI) breaking immune homeostasis and tolerance: a key role for T regulatory cells 79
An immunometabolic pathomechanism for chronic obstructive pulmonary disease 78
Obesity and susceptibility to autoimmune diseases 75
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis 74
Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation 74
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects 74
T follicular helper cells (TFH): From physiological to pathological aging 73
Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles 72
Ob-Stopping Obesity, Metabolic and Immune-Mediated Disorders 72
Obesity worsens central inflammation and disability in multiple sclerosis 70
Immuno-metabolic impact of the multiple sclerosis patients’ sera on endothelial cells of the blood-brain barrier 67
FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis 65
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects 65
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies 64
Metabolic pressure and the breach of immunological self-tolerance 63
Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunity 61
Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes 61
Leptin modulates autophagy in human CD4+CD25− conventional T cells 60
Divergent immunomodulatory effects of recombinant and urinary-derived FSH, LH, and hCG on human CD4+ T cells 60
The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution 60
Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses 60
Therapeutic opportunities to modulate immune tolerance through the metabolism-chromatin axis 59
Leptin-Induced mTOR Activation Defines a Specific Molecular and Transcriptional Signature Controlling CD4+ Effector T Cell Responses 58
Metabolism and Autoimmune Responses: The microRNA Connection 58
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 57
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. 56
The DEL-1-?3 integrin axis promotes regulatory T cell responses during inflammation resolution 56
HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling 55
CD4+ T-Cell Activation Prompts Suppressive Function by Extracellular Vesicle-Associated MicroRNAs 54
Nutritional control of immunity: Balancing the metabolic requirements with an appropriate immune function 49
Leptin as immune mediator: Interaction between neuroendocrine and immune system 49
Immunometabolic biomarkers of inflammation in Behcet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens 48
Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function 48
Cyclic AMP Modulates the Functional Plasticity of Immature Dendritic Cells by Inhibiting Src-like Kinases through Protein Kinase A-mediated Signaling 48
Neuro-Endocrine Networks Controlling Immune System in Health and Disease 47
1 Intracellular metabolic pathways control immune tolerance 47
Leptin: The Prototypic Adipocytokine and its Role in NAFLD 46
a key role of leptin in the control of regulatory T cell proliferation 44
Type 2 diabetes: How much of an autoimmune disease? 43
Hunger-promoting hypothalamic neurons modulate effector and regulatory T-cell responses 41
Reduced annexin A1 expression associates with disease severity and inflammation in multiple sclerosis patients 41
Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells 40
Pro-inflammatory biomarkers predictive of poor response to Interferon beta1a in multiple sclerosis 40
Role of Adipokines Signaling in the Modulation of T Cells Function 40
Metabolic fuelling of proper T cell functions 39
The Multifaceted Interface Between Cytokines and microRNAs: An Ancient Mechanism to Regulate the Good and the Bad of Inflammation 38
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome 37
Role of metabolism in neurodegenerative disorders 36
Regulatory T cell proliferative potential is impaired in human autoimmune disease 36
Animal models of Multiple Sclerosis 35
Metabolic Syndrome and the Immunological Affair with the Blood–Brain Barrier 35
Immune response and metabolism: novel targets for future therapeutic strategies in inflammation and autoimmunity 35
Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis 34
The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis? 33
Intracellular metabolic pathways control immune tolerance 32
Leptin and immune function, inflammation and angiogenesis 31
Leptin Modulates the Survival of Autoreactive CD4 + T Cells through the Nutrient/Energy-Sensing Mammalian Target of Rapamycin Signaling Pathway 30
Regulatory CD4 T cells: sensing the environment 30
At the crossroad of T cells, adipose tissue, and diabetes 30
Regulatory T cells in obesity: the leptin connection 27
Extracellular RNAs: A secret arm of immune system regulation 27
Leptin: Role of metabolism in the regulation of inflammation 27
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness 27
Role of Metabolism in the Immunobiology of Regulatory T Cells 24
Meta-Immunological Profiling of Children With Type 1 Diabetes Identifies New Biomarkers to Monitor Disease Progression 22
Leptin as a metabolic link to multiple sclerosis 21
Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism 20
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor 20
Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans 18
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a 8
Multiple sclerosis patients under treatment with interferon β1-a or ocrelizumab exhibit different T and B cell responses to SARS-CoV-2 vaccine 5
Totale 3.866
Categoria #
all - tutte 10.830
article - articoli 10.626
book - libri 110
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 94
Totale 21.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202416 0 0 0 0 0 0 0 0 1 0 0 15
2024/20251.422 89 5 62 10 158 106 95 95 88 73 291 350
2025/20262.299 153 220 181 466 297 96 314 74 173 153 87 85
2026/2027129 127 2 0 0 0 0 0 0 0 0 0 0
Totale 3.866